Global In vitro Toxicology Testing Market By Technology (Cell Culture Technology, OMICS Technology), Product (Consumables, Assays), Application (Systemic Toxicology, Dermal Toxicity), End-User (Pharmaceutical Industry, Diagnostics), & Region for 2024-2031
Report ID: 24017|No. of Pages: 202
Global In vitro Toxicology Testing Market By Technology (Cell Culture Technology, OMICS Technology), Product (Consumables, Assays), Application (Systemic Toxicology, Dermal Toxicity), End-User (Pharmaceutical Industry, Diagnostics), & Region for 2024-2031
In vitro Toxicology Testing Market Valuation – 2024-2031
The market expansion is ascribed to the ongoing advancements in the toxicological research and technological developments coupled with the increasing focus on the novel development of tailored medications. Increasing regulatory requirements for the safety assessment of chemicals and drugs are necessitating the adoption of in-vitro testing methodologies, surpassing USD 13.43 Billion valued in 2024 to reach a valuation of around USD 29.5 Billion by 2031.
In addition to this, there has been an increase in the awareness of the drawbacks and difficulties of conventional toxicological screening techniques. As a result, in-vitro testing is now more widely recognized as a useful method for determining a compound’s safety and effectiveness, thus enabling the niche market grow at a CAGR of 11.40% from 2024 to 2031.
Global In vitro Toxicology Testing Market: Definition/ Overview
In-vitro toxicology testing refers to the use of laboratory techniques to assess the toxicity of substances on biological cells or tissues outside of a living organism. These tests are conducted in a controlled environment, allowing for precise measurements and the study of specific biological processes. In-vitro toxicology testing is widely used to evaluate the safety of chemicals, drugs, and other substances before they are tested in animals or humans.
In-vitro toxicology testing serves as a valuable tool for assessing the safety and efficacy of various substances. Its applications extend across drug development, chemical safety evaluation, risk assessment, and regulatory compliance. By employing laboratory techniques to evaluate the toxicity of substances on biological cells or tissues, in-vitro testing offers valuable insights into potential risks and facilitates the development of safer and more effective products.
The development of more sophisticated in-vitro models, such as organ-on-a-chip systems, will improve the predictive accuracy of toxicity assessments. Additionally, the integration of artificial intelligence and machine learning will enable more efficient data analysis and modeling, leading to faster and more accurate toxicity predictions.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=24017
How are the Increasing Ethical Concerns Regarding the Animal Testing Fueling the Development of Global In vitro Toxicology Testing Market?
The Global In vitro Toxicology Testing Market is primarily driven by increasing ethical concerns regarding animal testing and stringent regulatory guidelines. According to the U.S. Environmental Protection Agency (EPA), as of 2023, over 10,000 chemicals are subject to the Toxic Substances Control Act, necessitating extensive safety testing. For instance, in March 15, 2024, Thermo Fisher Scientific announced a new high-throughput screening platform for in-vitro toxicology, aiming to accelerate drug discovery processes.
Rising R&D investments in pharmaceutical and biotechnology sectors are fueling market growth. The National Institutes of Health (NIH) reported a budget of $45.1 billion for biomedical research in fiscal year 2024, a significant portion allocated to developing alternative testing methods. for instance, in April 2, 2024, Charles River Laboratories unveiled a novel 3D cell culture system for more accurate toxicity predictions in drug candidates.
Technological advancements in cell culture techniques and the integration of artificial intelligence are enhancing the efficiency of in-vitro toxicology testing. The U.S. Food and Drug Administration (FDA) approved 55 novel drugs in 2023, with over 80% utilizing in-vitro methods during development. For instance, in February 20, 2024, Cyprotex, a leading CRO, launched an AI-powered platform for predicting drug-induced liver injury using in-vitro assays, potentially reducing drug attrition rates in clinical trials.
How are the Limited Predictive Accuracy Compared to In-Vivo Testing Impacting of the Global In vitro Toxicology Testing Market Growth?
The Global In vitro Toxicology Testing Market faces significant challenges despite its growth. Limited predictive accuracy of in-vitro models compared to in-vivo testing remains a concern. According to the FDA, only 11% of drugs that enter clinical trials ultimately receive approval, highlighting the need for more reliable preclinical testing methods. In March 2024, Charles River Laboratories announced a partnership with Instem to enhance their toxicology data management capabilities.
Regulatory hurdles and lack of standardization across different regions hinder market expansion. The European Chemicals Agency reported in 2023 that only 32% of REACH dossiers fully complied with information requirements, emphasizing the need for harmonized testing protocols. For instance, in January 2024, Thermo Fisher Scientific launched a new platform aimed at streamlining regulatory compliance for in-vitro toxicology testing across multiple markets.
High initial costs associated with advanced in-vitro technologies pose a barrier to adoption, especially for smaller laboratories. The National Institutes of Health allocated $1.2 billion for toxicology research in fiscal year 2024, but funding remains competitive. To combat this, Lonza introduced a cost-effective, high-throughput screening system in November 2023, designed to make advanced in-vitro toxicology testing more accessible to a broader range of research facilities.
Category-Wise Acumens
What are the Features Bolstering the Demand of Cell Culture Technology Segment?
The cell culture technology segment dominates the Global In vitro Toxicology Testing Market due to its ability to mimic human physiology accurately. According to the National Center for Advancing Translational Sciences (NCATS), as of 2023, over 30% of promising medications fail in human trials due to toxicity undetected in animal studies.
Advancements in 3D cell culture models and organ-on-a-chip technologies are driving the segment’s growth. The U.S. FDA reported that in 2023, approximately 25% of drug submissions included data from advanced cell culture models. In a significant development, on March 5, 2024, InSphero AG announced a partnership with a major pharmaceutical company to develop liver-on-a-chip models for high-throughput toxicity screening, potentially revolutionizing drug safety assessment procedures.
What Factors are Responsible to Project the Market Growth of Cellular Assay Segment?
The cellular assay segment has maintained a dominant position in the Global In vitro Toxicology Testing Market, driven by its ability to provide detailed insights into cellular responses to potential toxicants. According to the National Toxicology Program (NTP) of the U.S. Department of Health and Human Services, as of 2023, over 60% of toxicity screenings utilize cellular assays. For instance, in January 10, 2024, Lonza Group announced the expansion of its cellular assay portfolio with the launch of a new high-throughput 3D spheroid platform, enhancing the predictability of in-vitro toxicity assessments.
Advancements in cell culture technologies and the development of organ-on-a-chip models have further bolstered the cellular assay segment’s market share. The European Chemicals Agency (ECHA) reported in 2023 that cellular assays accounted for 70% of all in-vitro methods used for REACH compliance. For instance, in March 5, 2024, InSphero AG unveiled a novel liver-on-a-chip platform integrating multiple cell types for comprehensive hepatotoxicity testing, potentially revolutionizing drug safety assessments in preclinical stages.
Gain Access into Global In vitro Toxicology Testing Market Report Methodology
https://www.verifiedmarketresearch.com/select-licence/?rid=24017
Country/Region-wise Acumens
How are the Increased Adoption of In-Vitro Methods in Toxicology Studies Fueling the Demand in the North America region?
North America maintains a dominant position in the Global In vitro Toxicology Testing Market, driven by robust research infrastructure and stringent regulatory frameworks. The U.S. National Toxicology Program (NTP) reported in 2023 that over 65% of toxicology studies now incorporate in-vitro methods. For instance, in January 12, 2024, PerkinElmer announced the expansion of its Massachusetts-based in-vitro toxicology testing facility, doubling its capacity to meet growing demand in the region.
The region’s leadership is further bolstered by substantial funding and collaborative initiatives between industry and academia. The Canadian Institutes of Health Research (CIHR) allocated CAD 25 million for alternatives to animal testing in fiscal year 2023-2024. For instance, in March 28, 2024, Eurofins Scientific partnered with the University of California, San Diego to establish a center of excellence for advanced in-vitro toxicology methods, focusing on organ-on-chip technologies.
How are the Increasing R&D Investments and Biotechnology Growth Fueling the Asia Pacific In-vitro Toxicology Testing Growth?
The Asia Pacific region is poised for substantial growth in the in-vitro toxicology testing market, driven by increasing R&D investments and a rapidly expanding biotechnology sector. According to the Indian Ministry of Science and Technology, the country’s biotechnology industry reached a market size of $92 billion in 2023, with a significant portion dedicated to drug discovery and toxicology research.
Stringent regulations and growing awareness about animal welfare are further propelling market growth in the region. China’s National Medical Products Administration (NMPA) reported in 2023 that over 40% of toxicology studies for drug approvals now include in-vitro methods. for instance, in April 10, 2024, South Korean CRO Samsung Biologics unveiled a state-of-the-art in-vitro toxicology testing facility in Incheon, featuring advanced organ-on-chip platforms and AI-driven data analysis capabilities.
Competitive Landscape
The Global In vitro Toxicology Testing Market is a dynamic and competitive landscape, with a mix of established players and emerging challengers vying for market share. These players are actively working to strengthen their presence by implementing strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are dedicated to continuously improving their product line to meet the needs of a wide range of customers in different regions.
Some of the key players operating in the Global In vitro Toxicology Testing Market include:
- Charles River Laboratories International, Inc.
- SGS S.A.
- Merck KGaA
- Eurofins Scientific
- Abbott Laboratories
- Laboratory Corporation of America Holdings
- Evotec S.E.
- Thermo Fisher Scientific, Inc.
- Quest Diagnostics Incorporated
- Agilent Technologies, Inc.
- Catalent, Inc.
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- BioIVT
- Gentronix
Latest Developments
- In February 2023, Cyprotex US, LLC, an Evotec subsidiary, has moved from Watertown to Framingham, U.S., according to an announcement made by Evotec. “Expanding the new facility for faster turnaround time” was the motto of this migration.
- In March 2022, WuXi AppTec added a new plant in Chengdu broadening their toxicological footprint capabilities. They were able to guarantee improved service and quicker clinical study initiation thanks to this expansion.
- In January 2021, Charles River announced a collaboration with Cypre, Inc. to extend its 3D in vitro services for targeted therapy drug screening and cancer immunotherapy. Through this collaboration, the business was able to increase the scope of its in vitro testing services by utilizing Cypre’s patented Falcon-X 3D hydrogel patterning technology.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2021-2031 |
| Growth Rate | CAGR of ~11.40% from 2024 to 2031 |
| Base Year for Valuation | 2024 |
| Historical Period | 2021-2023 |
| Forecast Period | 2024-2031 |
| Quantitative Units | Value in USD Billion |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Players | Sangean, PANDA, ANJAN, Muzen Audio, Sony, Panasonic, GOLDYIP, Tecsun, PHILIPS, Degen |
| Customization | Report customization along with purchase available upon request |
Global In vitro Toxicology Testing Market, By Category
1. Technology:
- Cell Culture Technology
- High Throughput Technology
- Molecular Imaging Technology
- OMICS Technology
2. Product:
- Consumables
- Assays
- Instruments
- Software
- Services
3. Application:
3.1 Systemic Toxicology
3.1.1 Acute Toxicity
3.1.2 Carcinogenicity
3.1.3 Developmental Toxicity
3.1.4 Others
3.2 Dermal Toxicity
3.2.1 Skin Irritation Test
3.2.2 Skin Sensitization Test
3.2.3 Skin Corrosion Test
3.2.4 Phototoxicity Test
3.2.5 Others
3.3 Endocrine Disruption
3.3.1 Dioxins
3.3.2 Phthalates
3.3.3 Polychlorinated biphenyls (PCB)
3.4 Ocular Toxicity
3.4.1 Intravitreal
3.4.2 Subretinal
3.4.3 Others
3.5 Others
3.5.1 Immunotoxicity
3.5.2 Reproductive Toxicity
3.5.3 Neurotoxicity
3.5.4 Epigenetic Alterations
3.5.5 Genotoxicity
3.5.6 Others
4. End-User:
4.1 Pharmaceutical Industry
4.2 Cosmetics & Household Products
4.3 Academic Institutes & Research Laboratories
4.4 Diagnostics
4.4.1 Medical Devices
4.4.2 Others
4.5 Chemicals Industry
4.6 Food Industry
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as a future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL IN VITRO TOXICOLOGY TESTING MARKET
1.1 Introduction of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT
5.1 Overview
5.2 Assays
5.3 Software
5.4 Consumables
5.5 Services
5.6 Instruments
6 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
6.1 Overview
6.2 OMICS Technology
6.3 Cell Culture Technology
6.4 High Throughput Technology
6.5 Molecular Imaging Technology
7 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
7.1 Overview
7.2 In Silico
7.3 Biochemical Assay
7.4 Cellular Assay
7.5 Ex-vivo
8 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY APPLICATION
8.1 Overview
8.2 Endocrine Disruption
8.3 Dermal Toxicity
8.4 Systemic Toxicology
8.5 Ocular Toxicity
8.6 Others
9 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY END-USE
9.1 Overview
9.2 Cosmetics & Household Products
9.3 Pharmaceutical Industry
9.4 Diagnostics
9.5 Academic Institutes & Research Laboratories
9.6 Food Industry
9.7 Chemicals Industry
10 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the World
10.6.1 Latin America
10.6.2 Middle East and Africa
11 GLOBAL IN VITRO TOXICOLOGY TESTING MARKET COMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Abbott Laboratories
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Agilent Technologies
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Bio-Rad Laboratories
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Charles River Laboratories
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Covance
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 Eurofins Scientific
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 GE Healthcare
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 Labcorp
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 Lonza
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments
12.10 Merck KGaA
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments
13 Appendix
13.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
